neol, yes nice insider buys and unfortunately the bad phase III news of 11 dec 06 brought the sudden sharp decline : the intrinsic risk of bio-pharma.
geo : look at the judicious timing of my last alternative list add's. Im not a genious but A Good Timing will help a lot keeping the head out of waters :) .
(But i can't say it for RSDS (undervalued), PMRS (high risk) lol : my bad. PMRS i would say "high risk/max loss" haha.)